Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nicholas R. Akins"'
Autor:
Madeleine F. Jennewein, Anna J. MacCamy, Nicholas R. Akins, Junli Feng, Leah J. Homad, Nicholas K. Hurlburt, Emilie Seydoux, Yu-Hsin Wan, Andrew B. Stuart, Venkata Viswanadh Edara, Katharine Floyd, Abigail Vanderheiden, John R. Mascola, Nicole Doria-Rose, Lingshu Wang, Eun Sung Yang, Helen Y. Chu, Jonathan L. Torres, Gabriel Ozorowski, Andrew B. Ward, Rachael E. Whaley, Kristen W. Cohen, Marie Pancera, M. Juliana McElrath, Janet A. Englund, Andrés Finzi, Mehul S. Suthar, Andrew T. McGuire, Leonidas Stamatatos
Publikováno v:
Cell Reports, Vol 36, Iss 2, Pp 109353- (2021)
Summary: SARS-CoV-2 is one of three coronaviruses that have crossed the animal-to-human barrier and caused widespread disease in the past two decades. The development of a universal human coronavirus vaccine could prevent future pandemics. We charact
Externí odkaz:
https://doaj.org/article/f492dbc1e9954938a7e8625d4e1dc65e
Autor:
Swati Singh, Leah J. Homad, Nicholas R. Akins, Claire M. Stoffers, Stefan Lackhar, Harman Malhi, Yu-Hsin Wan, David J. Rawlings, Andrew T. McGuire
Publikováno v:
Cell Reports Medicine, Vol 1, Iss 3, Pp 100033- (2020)
Summary: Epstein-Barr virus (EBV) is a cancer-associated pathogen for which there is no vaccine. Successful anti-viral vaccines elicit antibodies that neutralize infectivity; however, it is unknown whether neutralizing antibodies prevent EBV acquisit
Externí odkaz:
https://doaj.org/article/5a07c5ee5e3746b3b84e49969e6834a5
Autor:
Madeleine F. Jennewein, Leah J. Homad, Kristen W. Cohen, Junli Feng, M. Juliana McElrath, K. Rachael Parks, Rachael E Nelson, Nicholas R. Akins, Janet A. Englund, Helen Y. Chu, Andrew T. McGuire, Anna J. MacCamy, Leonidas Stamatatos, Yu-Hsin Wan, Suruchi Singh, Emilie Seydoux, Andrew B. Stuart, Nicholas K. Hurlburt, Marie Pancera
Publikováno v:
bioRxiv : the preprint server for biology.
B cells specific for the SARS-CoV-2 S envelope glycoprotein spike were isolated from a COVID-19-infected subject using a stabilized spike-derived ectodomain (S2P) twenty-one days post-infection. Forty-four S2P-specific monoclonal antibodies were gene
Autor:
Madeleine F. Jennewein, Marie Pancera, Suruchi Singh, M. Juliana McElrath, K. Rachael Parks, Andrew T. McGuire, Michael Boeckh, Emilie Seydoux, Rachael E. Whaley, Leah J. Homad, Andrew B. Stuart, Nicholas K. Hurlburt, Yu Hsin Wan, Nicholas R. Akins, Leonidas Stamatatos, Anna J. MacCamy, Helen Y. Chu, Janet A. Englund, Kristen W. Cohen, Junli Feng
Publikováno v:
Immunity
bioRxiv
article-version (status) pre
article-version (number) 1
bioRxiv
article-version (status) pre
article-version (number) 1
Antibody responses develop following SARS-CoV-2 infection, but little is known about their epitope specificities, clonality, binding affinities, epitopes and neutralizing activity. We isolated B cells specific for the SARS-CoV-2 envelope glycoprotein
Autor:
Nicholas R. Akins, Leah J. Homad, David J. Rawlings, Claire M. Stoffers, Yu-Hsin Wan, Swati Singh, Harman Malhi, Andrew T. McGuire, Stefan Lackhar
Publikováno v:
Cell Reports Medicine, Vol 1, Iss 3, Pp 100033-(2020)
Cell reports. Medicine
Cell reports. Medicine
SUMMARY Epstein-Barr virus (EBV) is a cancer-associated pathogen for which there is no vaccine. Successful anti-viral vaccines elicit antibodies that neutralize infectivity; however, it is unknown whether neutralizing antibodies prevent EBV acquisiti